Tissue distribution and tumor uptake of folate receptor–targeted epothilone folate conjugate, BMS-753493, in CD2F1 mice after systemic administration
To assess targeting of an epothilone folate conjugate (BMS-753493) to the folate receptor (FR)-overexpressed tumor in mice bearing both FR+ and FR– tumors, a series of experiments were conducted by quantitative whole-body autoradiography (QWBA) and LC–MS/MS following i.v. administration of BMS-75349...
Main Authors: | Hong Shen, Lifei Wang, Weiqi Chen, Krista Menard, Yang Hong, Yuan Tian, Samuel J. Bonacorsi, W. Griffith Humphreys, Francis Y. Lee, Jinping Gan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-09-01
|
Series: | Acta Pharmaceutica Sinica B |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211383516301058 |
Similar Items
-
Folate and macrophage folate receptor-β in idiopathic pulmonary fibrosis disease: the potential therapeutic target?
by: Yaqian Qu, et al.
Published: (2020-11-01) -
Enhancement of Binding Affinity of Folate to Its Receptor by Peptide Conjugation
by: Roopa Dharmatti, et al.
Published: (2019-04-01) -
Novel insights in folate receptors and transporters: implications for disease and treatment of immune diseases and cancer
by: Jansen Gerrit, et al.
Published: (2015-06-01) -
Prospects in folate receptor-targeted radionuclide therapy
by: Cristina eMüller, et al.
Published: (2013-09-01) -
Selenofolate inhibits the proliferation of IGROV1 cancer cells independently from folate receptor alpha
by: Ali Razaghi, et al.
Published: (2021-06-01)